Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis.

Wawruszak, Anna; Luszczki, Jarogniew; Okon, Estera; Czerwonka, Arkadiusz; Stepulak, Andrzej

Wawruszak, Anna; Luszczki, Jarogniew; Okon, Estera; Czerwonka, Arkadiusz; Stepulak, Andrzej.

Afiliação

Wawruszak A; Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.
Luszczki J; Department of Pathophysiology, Medical University of Lublin, 20-090 Lublin, Poland.
Okon E; Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.
Czerwonka A; Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.
Stepulak A; Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.

Int J Mol Sci ; 23(12)2022 Jun 09.

Article em En | MEDLINE | ID: mdl-35742901

Assuntos

Sirtuínas; Neoplasias de Mama Triplo Negativas; Apoptose; Linhagem Celular Tumoral; Proliferação de Células; Humanos; Naftalenos; Paclitaxel; Pirimidinonas; Neoplasias de Mama Triplo Negativas/patologia

Palavras-chave

anti-cancer drugs; breast cancer (BC); cambinol (CAM); combined therapy; histone deacetylase inhibitor (HDI); isobolography; paclitaxel (PAX); sirtuin (SIRT); sirtuin inhibitor (SIRTi)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sirtuínas / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google